医药魔方 / 最新资讯 / 正文

2019开年前10天,美国490种处方药涨价

医药魔方 医药魔方 来源:医药魔方
2019-01-12
药品价格
原文

1月10日,强生宣布加入涨价大军,集中上调超过20个处方药的价格,包括银屑病药物Stelara(乌司奴单抗)、前列腺癌药物Zytiga(阿比特龙)、抗凝药Xarelto(利伐沙班)等多款畅销处方药。据Rx Savings Solutions数据显示,强生此次处方药涨幅在6%-7%之间。

 

在强生宣布涨价的当天,美国国会民主党成员刚提交了一份为美国消费者降低处方药价格的议案。

 

强生表示,其所售全部药品的2019年平均定价(list price)相比2018年上涨了4.2%,但是平均净价(net price)实际上是下降的。因为企业通常要跟付费方谈判确定一个报销补偿或折扣,以扩大患者覆盖。强生同时表示,2019年不会再调高其他药品的定价了。

 

美国药价在2019年以普涨开局。截至1月2日,美国有250多种处方药宣布涨价。截至1月10日,则有接近490种处方药宣布涨价,其中包括赛诺菲的胰岛素价格上调4.4%~5.2%,诺和诺德的胰岛素价格上调4.9%。

 

赛诺菲表示其涨价的幅度低于美国医疗保险和医疗补助服务中心医疗通货膨胀预测,而且2019年药品净价预计是降低的。诺和诺德表示上调定价是为了补偿向保险商和药房福利机构提供的折扣或退款。

 

实际上,在律师和特朗普总统的压力下,美国处方药在2019年的涨价态势要弱于2018年。2018开年之后的前10天,美国共有650种处方药宣布涨价。

 

美国是一个允许制药企业自主定价的医药市场。美国药品的价格通常会高于其他通过直接或间接手段管控药价的国家。美国卫生与公众服务部已经出台了期望可以降低药价的政策,希望患者可以更多享受到医保付费方与企业谈判争取到的折扣。


机器翻译

On January 10, Johnson & Johnson announced that it would join the price increase army and focus on raising the prices of more than 20 prescription drugs, including the psoriasis drug Stelara, the prostate cancer drug Zytiga, and the anticoagulant Xarelto.According to Rx Savings Solutions data, Johnson's prescription drug growth is between 6% and 7%.

On the day Johnson & Johnson announced price increases, members of the Democratic Party of the United States Congress just submitted a bill to lower the price of prescription drugs for US consumers.

Johnson & Johnson said that the average price of all its drugs sold in 2019 was higher than in 2018 4.2%, but the average net price actually drops.Because companies usually negotiate with the paying party to determine a reimbursement or discount to expand patient coverage.Johnson & Johnson also said that the pricing of other drugs will not be increased in 2019.

US drug prices started with a general increase in 2019.As of January 2, more than 250 prescription drugs in the United States announced price increases.As of January 10, there were close to 490 prescription drugs announced price increases, including Sanofi's insulin price hike 4.4% ~ 5.2%, Novo Nordisk's insulin price increase 4.9%.Novo Nordisk said the increase was to compensate for discounts or refunds to insurers and pharmacy welfare agencies.

In fact, under the pressure of lawyers and President Trump, the price increase of prescription drugs in the United States in 2019 was weaker than in 2018.In the first 10 days of 2018, a total of 650 prescription drugs in the United States announced price increases.

The United States is a pharmaceutical market that allows pharmaceutical companies to set their own prices.The price of drugs in the United States is usually higher than in other countries that control drug prices directly or indirectly.The U.S. Department of Health and Human Services has introduced a policy that expects to lower drug prices, hoping that patients can enjoy more discounts negotiated between Medicare payers and companies.

扫码实时看更多精彩文章

版权及免责声明 本文由医药魔方原创,版权归医药魔方所有。未经许可,严禁任何媒体或个人以任何形式摘编、改写、复制、转载本文内容。对于恶意侵权行为,医药魔方保留采用法律手段追究的权利。媒体内容及商务合作请联系医药魔方工作人员(微信号:medicube)

魔方微信公众号